Lowest-Rated StocksLowest-RatedNYSE:SOLV Solventum (SOLV) Stock Price, News & Analysis $66.56 -0.07 (-0.11%) (As of 12/24/2024 05:19 PM ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends About Solventum Stock (NYSE:SOLV) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Solventum alerts:Sign Up Key Stats Today's Range$65.85▼$66.7050-Day Range$66.56▼$75.0752-Week Range$47.16▼$96.05Volume252,375 shsAverage Volume1.61 million shsMarket Capitalization$11.50 billionP/E RatioN/ADividend YieldN/APrice Target$68.29Consensus RatingHold Company OverviewSolventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.Read More… Solventum Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks28th Percentile Overall ScoreSOLV MarketRank™: Solventum scored higher than 28% of companies evaluated by MarketBeat, and ranked 808th out of 945 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.0 / 5Analyst RatingHold Consensus RatingSolventum has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, 9 hold ratings, and 1 sell rating.Amount of Analyst CoverageSolventum has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Solventum's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings Growth-16.57% Earnings GrowthEarnings for Solventum are expected to decrease by -16.57% in the coming year, from $6.58 to $5.49 per share.Price to Earnings Growth RatioSolventum has a PEG Ratio of 1.51. PEG Ratios above 1 indicate that a company could be overvalued. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.61% of the float of Solventum has been sold short.Short Interest Ratio / Days to CoverSolventum has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Solventum has recently decreased by 2.96%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSolventum does not currently pay a dividend.Dividend GrowthSolventum does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted2.61% of the float of Solventum has been sold short.Short Interest Ratio / Days to CoverSolventum has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Solventum has recently decreased by 2.96%, indicating that investor sentiment is improving. News and Social Media3.2 / 5News Sentiment0.74 News SentimentSolventum has a news sentiment score of 0.74. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 9 news articles for Solventum this week, compared to 8 articles on an average week.Search InterestOnly 4 people have searched for SOLV on MarketBeat in the last 30 days. This is a decrease of -64% compared to the previous 30 days.MarketBeat Follows4 people have added Solventum to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company OwnershipN/AInsider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Solventum insiders have not sold or bought any company stock.Read more about Solventum's insider trading history. Receive SOLV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Solventum and its competitors with MarketBeat's FREE daily newsletter. Email Address SOLV Stock News HeadlinesSolventum Corp. stock falls Tuesday, underperforms marketDecember 25 at 3:50 AM | marketwatch.comSolventum Corporation Common Stock (SOLV) Real-TimeDecember 23 at 11:07 PM | nasdaq.comMysterious drone activity triggers massive 1,366% surgeIf mysterious drones buzzing over the East Coast weren’t on your radar this year, you’re not alone. But here’s what you really need to know: An early warning signal tipped off investors to a tiny drone stock that later skyrocketed 1,366%.December 25, 2024 | Insiders Exposed (Ad)Solventum Corp. stock falls Monday, underperforms marketDecember 23 at 6:05 PM | marketwatch.comGE Made Spinoffs Cool Again. FedEx Is Joining the Club.December 20, 2024 | yahoo.comSolventum Corp. stock rises Friday, still underperforms marketDecember 20, 2024 | marketwatch.comAfter GE’s Spinoff Success, What’s Next for Honeywell, FedExDecember 20, 2024 | yahoo.comHoneywell Pops As It Mulls This Move Echoing GE AerospaceDecember 17, 2024 | msn.comSee More Headlines SOLV Stock Analysis - Frequently Asked Questions How have SOLV shares performed this year? Solventum's stock was trading at $66.90 at the beginning of 2024. Since then, SOLV stock has decreased by 0.5% and is now trading at $66.56. View the best growth stocks for 2024 here. How were Solventum's earnings last quarter? Solventum Co. (NYSE:SOLV) posted its quarterly earnings results on Thursday, August, 8th. The company reported $1.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.46 by $0.10. Solventum's revenue was up .2% on a year-over-year basis. Who are Solventum's major shareholders? Solventum's top institutional shareholders include Trian Fund Management L.P. (4.13%), State Street Corp (3.54%), Geode Capital Management LLC (1.94%) and Hotchkis & Wiley Capital Management LLC (1.04%). How do I buy shares of Solventum? Shares of SOLV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Solventum own? Based on aggregate information from My MarketBeat watchlists, some other companies that Solventum investors own include Chevron (CVX), American Water Works (AWK), The RMR Group (RMR), Bristol-Myers Squibb (BMY), DiamondRock Hospitality (DRH), Waste Connections (WCN) and AUO (AUOTY). Company Calendar Last Earnings8/08/2024Today12/25/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNYSE:SOLV Previous SymbolNYSE:SOLV CUSIPN/A CIK1964738 Webwww.solventum.com Phone651-733-1110FaxN/AEmployees22,000Year FoundedN/APrice Target and Rating Average Stock Price Target$68.29 High Stock Price Target$82.00 Low Stock Price Target$54.00 Potential Upside/Downside+2.6%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage11 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E Ratio10.12 P/E Growth1.51Net IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio2.45 Current Ratio1.15 Quick Ratio0.83 Sales & Book Value Annual Sales$8.26 billion Price / Sales1.39 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares172,754,000Free FloatN/AMarket Cap$11.50 billion OptionableOptionable BetaN/A 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report This page (NYSE:SOLV) was last updated on 12/25/2024 by MarketBeat.com Staff From Our Partners$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Solventum Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Solventum With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.